article thumbnail

Top Ten infoChachkie Entries Of 2011

InfoChachkie

I began publishing my blog in 2008. I was hesitant to use my own name, as I did not want my blog to be perceived as a self-promotional vanity project. In addition, my role as Partner at Rincon Venture Partners provided me with a business reason to invest additional time and effort into my humble blog. I was not disappointed.

article thumbnail

Why You Should Put Yourself Out There and Try New Products

Both Sides of the Table

In 2008 I started VC blogging. I had blogged when I was an entrepreneur. In 2011 I started using Instagram. Here’s the thing: If you never try new product and new networks you’ll never learn anything. I went to an industry event where people actually called me self-centered for writing publicly.

Snapchat 150
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

BLOGGER ALERT: How to Start a Blog and Make Money Blogging

Tech Zulu Event

In this article you’ll discover how to start a blog that makes money. There are four types of blogs; written blogs, video blogs, photo blogs and a combination of these. We’ll primarily be discussing written blogs. There are two different components to make money blogging. Let’s discuss. Not really.

article thumbnail

Pharma’s Productivity Problem: Finding More Blockbuster Drugs

Xconomy

A recent Wall Street Journal article that raised the possibility of Biogen as the target of another huge pharma buyout cited the lack of productivity as a major driver of M&A in the pharmaceutical industry. The authors made the point that, given the size of companies today, a single garden-variety blockbuster hardly moves the needle.

Product 40
article thumbnail

LA CEOs

SoCal Tech Calendar

Thursday, July 7, 2011 -- LA CEOs, an education and support group for CEOs presents: New Media Training. The power of a video of you speaking or your own words in a blog introducing your product, service, a key event is tremendous and every CEO should leverage it. The potential for missteps and misinterpretation is huge.

Training 113
article thumbnail

Two Big Pharma Alliances End in Nixed Deals. Here’s What Happened.

Xconomy

In 2011, Pfizer paid $22.5 million up front for the rights to license and develop products containing rivipansel, a compound hoped to address inflammation. The lead therapeutic target for rivipansel was vaso-occlusive crisis, a complication of sickle cell disease in which the abnormally shaped red blood cells obstruct.

Develop 109
article thumbnail

Guerilla Marketing, Brad Feld Style

InfoChachkie

companies should… focus on building amazing products. If you have amazing products, the marketing of those products is trivial. If you have $hitty products, the marketing is impossible. Instead of focusing on marketing as an activity… integrate it into (your) products.”. Brad Feld, Managing Director, Foundry Group.

Marketing 233